People · Operator
Named in public records as an officer, director or promoter · active 2010–2021 · Other Energy, Other, Retailing, Manufacturing, AI / ML, Mining & Resources
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| FastCAP Systems Corp | — | Other Energy | Series C | $109.1M | $347.7M | 2016 |
| Numi, Inc. | — | Other | Series B | $34.7M | $265.8M | 2010 |
| Huckberry Inc. | — | Retailing | Series A | $13.1M | $32.1M | 2019 |
| Tcho Ventures Inc | — | Manufacturing | Series A | $4.2M | $42.1M | 2016 |
| Unanimous AI, Inc. | — | AI / ML | Seed | $3.9M | $3.3M | 2017 |
| Santacruz Silver Mining Ltd. | — | Mining & Resources | Seed | $3.2M | $6.5M | 2012 |
| Neurotez Inc. | — | Pharmaceuticals | Seed | $2.0M | $76.0M | 2020 |
| Essex Minerals Inc. | — | Mining & Resources | Pre-Seed | $872K | $466K | 2020 |
| J2 Bio-Pharma, LLC | — | Pharmaceuticals | Pre-Seed | $345K | $16.3M | 2016 |
| FHKA Holdings LLC | — | Pharmaceuticals | Pre-Seed | $300K | $8.3M | 2021 |
James Harris at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside James Harris on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| James Fares | 2 | 3 |
| Arunas Chesonis | 1 | 11 |
| James Joaquin | 1 | 10 |
| Marcel Bens | 1 | 8 |
| Jed Smith | 1 | 8 |
| James Hutton | 1 | 6 |
| Keith Wilson | 1 | 4 |
| Saif Qazi | 1 | 4 |
| AHMED RAHIM | 1 | 4 |
| ROBERT McMORRAN | 1 | 4 |
| Eric Kish | 1 | 3 |
| Michael Rand | 1 | 2 |
| Riccardo Signorelli | 1 | 2 |
| Vivek Agastya | 1 | 2 |
| Jiang-Ling Du | 1 | 2 |
| Jukka Karjalainen | 1 | 2 |
| John Cooley | 1 | 2 |
| MEGHAN LEWIS | 1 | 2 |
| Hans Heer | 1 | 2 |
| Neil Blomquist | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.